A discreet vascular, neurologic, and hormonal review first
Stem cell therapy for erectile dysfunction in Istanbul, Turkey
Our Istanbul urology team reviews your ED cause, cardiovascular risk, and standard care before discussing a closely monitored cell therapy option.
Condition-specific editorial anatomy. Explanatory labels remain in accessible text.
Direct answer
What the current evidence says
We start with your cardiovascular, hormonal, and medication history, because ED can be an early marker of vascular disease. Small early-phase studies of specific intracavernosal cell products in selected patients show some promise, but we're candid that heterogeneous products and small samples mean we can't promise restored vessels or medication independence. Request your free medical evaluation for a discreet, honest review of your options.
Evidence position
What is known, what is investigational, and what is not demonstrated
Careful, discreet evaluation and monitored option
ED can be an early marker of cardiovascular disease, so we review blood pressure, diabetes, lipids, and smoking as part of every evaluation.
Local injection has local risk
PDE5 inhibitors, vacuum devices, counseling, and intracavernosal medicines have established roles for appropriate patients, and we keep them central.
We won't overstate a score change
Results vary between patients and stem cell therapy is not a guaranteed cure — an intracavernosal study doesn't support an IV infusion claim.
Evidence ledger
Read the actual study, including the result that did not change
Each row keeps product identity, route, endpoint, and limitation together so one trial cannot become a generic treatment claim.
01 Cell therapy for erectile dysfunction meta-analysis
Open source- Product
- Heterogeneous autologous and allogeneic cell preparations
- Route
- Intracavernosal injection
- Design
- Systematic review of small early clinical studies
- Finding
- Some studies reported short-term IIEF or erectile-function signals.
- Limitation
- Small samples, varied causes and products, limited controls, and uncertain durability do not establish routine efficacy.
Clinical map
Start with the diagnosis, stage, and treatment context
We define your exact cause, cardiovascular safety, and the specific product and route before any procedure.
Established care comes first
- Cardiometabolic assessment: We evaluate exercise safety, blood pressure, diabetes, and overall cardiovascular risk first.
- Stepwise ED treatment: We help you access PDE5 inhibitors where safe, vacuum devices, counseling, or intracavernosal medicines.
- Cause-specific care: We address endocrine disease, medication effects, and pelvic rehabilitation alongside your treatment.
- 01
Vascular and metabolic
Atherosclerosis, diabetes, hypertension, and smoking are common contributors we screen for.
- 02
Neurologic or post-surgical
Prostate surgery, pelvic treatment, and neurologic conditions change your prognosis and plan.
- 03
Hormonal, medication, and psychosexual
Testosterone deficiency, medicines, and relationship factors can all play a role, and we address them together.
Product and route
A mechanism is not a clinical outcome
- 01
Local injection has local risk
Intracavernosal administration requires sterile technique, and we plan carefully for pain, bleeding, and infection risk.
BoundaryEvidence applies only to the studied product, population, dose, route, comparator, and endpoint.
- 02
We won't overstate a score change
A change in IIEF score doesn't prove new vessels or durable medication independence, and we tell you that clearly.
BoundaryEvidence applies only to the studied product, population, dose, route, comparator, and endpoint.
Outcomes before travel
Decide what meaningful change would look like
A baseline and a time point matter more than an isolated testimonial. These measures should be chosen before any intervention.
- 01
International Index of Erectile Function
- 02
Erection Hardness Score
- 03
Spontaneous versus assisted intercourse success
- 04
PDE5 inhibitor or injection requirement
- 05
Adverse events and durability
Specialist review
What a complete Istanbul review needs
Our Istanbul urology team reviews your ED cause, cardiovascular risk, and standard care before discussing a closely monitored cell therapy option.
Records and baseline
- Onset, rigidity, morning erections, libido, and pain
- Diabetes, cardiovascular, neurologic, and medicine history
- Blood pressure, cardiometabolic tests, and testosterone evaluation when indicated
- Prior PDE5 inhibitors, vacuum, injections, or surgery and response
- The exact product, route, and safety plan we recommend for you
Safety and planning checks
- Unstable chest symptoms or cardiovascular disease needs medical clearance before sexual activity or elective treatment.
- Nitrate medicines can interact dangerously with PDE5 inhibitors, so we always ask about your full medication list.
- Your Istanbul consultation is private and includes a written comparison with established urologic options.
Transparent planning
Build the medical plan before the package
A quote should follow record review, product disclosure, route rationale, and a written follow-up plan. This page does not invent a universal price.
- Unstable chest symptoms or cardiovascular disease needs medical clearance before sexual activity or elective treatment.
- Nitrate medicines can interact dangerously with PDE5 inhibitors, so we always ask about your full medication list.
- Your Istanbul consultation is private and includes a written comparison with established urologic options.
Questions the plan must answer
- 01
Local injection has local risk: Intracavernosal administration requires sterile technique, and we plan carefully for pain, bleeding, and infection risk.
- 02
We won't overstate a score change: A change in IIEF score doesn't prove new vessels or durable medication independence, and we tell you that clearly.
Primary reading
Guidelines, trials, and regulatory context
FAQ
Questions patients ask before an Istanbul review
Request Medical Evaluation
Begin a personalized treatment conversation with our medical team.
Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.